Award recordCONTRACT

CSL BEHRING L.L.C.

PIID VA26116F1413· VHA· 261-NETWORK CONTRACT OFFICE 21· 6505 · DRUGS AND BIOLOGICALS· FY2016· $12,789 net obligations· UEI H3WKVE9VBLY3· PA

Description

ZEMAIRA DRUG 953MG VIAL

First action · last action
2016-03-31 · 2016-03-31
Transactions
1
First transaction's obligation
$12,789
Base + all options value (sum of deltas)
$12,789
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$12,789$0Base award · 2016-03-31 · this action $12,789 · running total $12,789
  • Base2016-03-31+$12,789= $12,789
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-03-31+$12,789$12,789ZEMAIRA DRUG 953MG VIAL

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26116F1244SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$31,450FY2016
VA26116F1240SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$7,234FY2016
VA26116F1213SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$62,900FY2016
VA26116J1285SEQIRUS USA INC261-NETWORK CONTRACT OFFICE 21$88,155FY2016
VA26116J1301SANOFI VACCINES US INC.261-NETWORK CONTRACT OFFICE 21$255,015FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26116F1413_3600_V797D50358_3600 · retrieved 2026-09-26.